There was a mistake in Figure 1C (control and 30 μM groups) as published. During figure preparation, the images for the splenocytes control group and the 30 μM group in Figure 1C were incorrectly selected, resulting in a misrepresentation of the experimental data. The corrected Figure 1 appears below.
FIGURE 1.
Non-toxic Hes attenuated RANKL-induced osteoclast formation and function in vitro. (A) Cell viability of osteoclast precursors after Hes treatments for 24 h. (B) Linear correlation between OD values and cell numbers. (C) RANKL-induced osteoclastogenesis after Hes treatments in three types of preosteoclasts, RAW 264.7 cells, splenocytes, and BMMs. (D) Formation of RANKL-induced F-actin rings after Hes treatments. (E) Formation of RANKL-stimulated bone resorption pits after Hes treatments. *p < 0.05 compared with controls, **p < 0.01 compared with controls.
This error does not affect the interpretation or conclusions of the article in any way.
The original article has been updated.
Footnotes
Edited and reviewed by: Peter Vee Sin Lee, The University of Melbourne, Australia
Generative AI statement
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.